[NBIX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
09-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 77.74%
YoY- 65.96%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 622,100 590,200 515,300 515,200 498,800 452,700 420,400 29.76%
PBT 190,300 98,600 34,500 198,200 115,600 121,600 -103,300 -
Tax 60,500 33,600 -8,900 50,500 32,500 26,100 -26,700 -
NP 129,800 65,000 43,400 147,700 83,100 95,500 -76,600 -
Tax Rate -31.79% -34.08% 25.80% -25.48% -28.11% -21.46% - -
Total Cost 492,300 525,200 471,900 367,500 415,700 357,200 497,000 -0.62%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 20.86 11.01 8.42 28.67 16.66 21.10 -18.22 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 1.28 0.64 0.43 1.50 0.85 0.98 -0.79 -
EPS Diluted 1.24 0.63 0.42 1.44 0.82 0.95 -0.79 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.